Immunoglobulin antitsitomegalovirusny

Иммуноглобулин антицитомегаловирусный Drug photo

The description is actual on 18.12.2014

  • Latin name: Immunoglobulinum humanum anticytomegalovirusum
  • ATH code: J06B B09
  • Active ingredient: Immunoglobulin antitsitomegalovirusny person
  • Producer: Biofarm Plasma

Structure

As a part of medicine there is an active ingredient immunoglobulin antitsitomegalovirusny the person, and also glycine as the stabilizer.

Release form

Is issued in the form of solution which contains in ampoules, boxes from a cardboard contain about 10 ampoules.

Pharmacological action

Immunoglobulin antitsitomegalovirusny is the biological fraction possessing the expressed immunological activity which is distinguished from plasma of the person. An active basis of medicine are  antibodies, specific to a cytomegalovirus, namely — immunoglobulin G.

In view of virusoneytralizuyushchy action drug renders specific activity. Besides it provides immunomodulatory influence as immunoglobulin G drug affects immune system of an organism. As a result, increase of immunity and increase in nonspecific resistance is noted.

Pharmacokinetics and pharmacodynamics

Data are absent.

Indications to use

Immunoglobulin antitsitomegalovirusny is appointed for therapy of a tsitomegalovirusny infection with different clinical manifestations, both at children, and at adults. In particular drug is shown if at the person such diseases and states are noted:

  • The Tsitomegalovirusny infection at pregnant women on condition of the complicated anamnesis, drug is appointed with the purpose to prevent pregnancy course disturbances.
  • Tsitomegalovirusny infection at nonpregnant women on condition of existence in the anamnesis of complications, with the purpose to prevent those disturbances which can be shown at pregnancy afterwards.
  • Tsitomegalovirusny infection at pregnant women on condition of lack of complications in the anamnesis, for the purpose of the prevention of complications.
  • Displays of a tsitomegalovirusny infection at children of the first years of life and at newborn babies who were given birth infected or having clinical signs of infection with women.
  • Tsitomegalovirusny infection at adult patients at whom defeats of TsNS are noted.

Contraindications

It is not necessary to administer the drug to people at whom in the anamnesis heavy allergic manifestations after introduction of proteinaceous blood preparations are noted.

Side effects

After to the patient Immunoglobulin antitsitomegalovirusny, in some, exceptional cases is entered, manifestation of a hyperemia as local reaction, and also the small growth of indicators of body temperature in the first days after administration of solution can be noted.

At people with the changed reactivity manifestation of any allergic reactions is possible. Development of an acute anaphylaxis is very seldom possible. Therefore after receiving an injection the patient has to stay under supervision of the doctor on an extent of 30 minutes.

Application instruction (Way and dosage)

Immunoglobulin antitsitomegalovirusny is entered only intramusculary, intravenous administration is forbidden.

For the purpose of therapy of a tsitomegalovirusny infection at the burdened obstetric anamnesis, both at pregnant women, and at nonpregnant women, it is necessary to enter contents of one ampoule of 4-5 times. At the same time the interval between introductions makes from 3 to 5 days.

For the purpose of therapy of a tsitomegalovirusny infection at the people suffering from defeats of TsNS contents of 3 ampoules of 5 times are entered, at the same time the break between introductions of means makes 2 days.

At therapy of a tsitomegalovirusny infection at newborns the drug needs to be administered three times a day in a dose at the rate of 0,5 ml on 1 kg of body weight, at the same time the break between introductions of medicine has to make 2-3 days.

At therapy of a tsitomegalovirusny infection at children of the first years of life it is necessary to enter contents of 1 ampoule of 4-5 times, at the same time the interval between introductions makes 5 days.

Overdose

About overdose data are not provided.

Interaction

Expediency of the combined immunoglobulin and Foskarnet or Gantsiklovir is noted.

It is impossible to enter together with any of drugs in one volume.

Terms of sale

In drugstores it is implemented according to the recipe.

Storage conditions

It is necessary to store and transport medicine at observance of temperature of 2-8 °C. It is not necessary to freeze solution.

Period of validity

It is possible to store 2 years.

Special instructions

The people having an allergy, or having allergic diseases in the anamnesis have to in day when it entered immunoglobulin, and in the next three days to accept antihistamines. People who have immunopathological system diseases can enter immunoglobulin only against necessary treatment.

After carrying out a course of treatment drug the patient can pass vaccination with use of live vaccines only in 2-3 months after completion of such treatment.

To children

In the presence of indications it is applied to treatment of newborns and children.

Apteka24

  • Immunoglobulin of an antitsitomegalovirusnyybiofarm (Ukraine, Kiev)
Section: Immunity increase Antiviral
in more detail

Education: "Pharmacy" graduated from the Rovno state basic medical college majoring in. Graduated from the Vinnytsia state medical university of M. I. Pirogov and internship on its base.

Experience: From 2003 to 2013 – worked at positions of the pharmacist and manager of a pharmaceutical booth. It is awarded by diplomas and distinctions for long-term and honest work. Articles on medical subject were published in local editions (newspaper) and on various Internet portals.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Immunoglobulin antitsitomegalovirusny surely consult with the attending physician.